Health Condition 1: null- Third Molar surgery
Conditions
Interventions
Intervention1: Dexamethasone 8 mg submucosally: 8 mg dexamethasone will be infiltrated submucosally around the site of surgery at approximately 5â??10 min. preoperatively.
Control Intervention1: Methy
Sponsors
All India Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of age group 18-40 years 2. Pell and Gregory Class II with position A would be minimum selection criteria. 3. Third molar involved should be free of caries, extensive periodontal disease, pain, or other inflammatory symptoms at the time of operation
Exclusion criteria
Exclusion criteria: 1. Patients with immunocompromised status, uncontrolled systemic disease, presence of infection, pregnancy or lactation. 2. Absolute contraindications to corticosteroid use like patients with tuberculosis, active viral or fungal infections, active acne vulgaris, and primary glaucoma, a history of acute psychosis or psychopathic tendencies and allergies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacy of 40 mg submucosal methylprednisolone and 8 mg submucosal dexamethasone in reducing pain, swelling and trismus in contrast to no steroids in control patients following surgical removal of impacted mandibular third molars.Timepoint: Data evaluation of patients - 10 months Next 2months Statistical Evaluation and Final Result | — |
Secondary
| Measure | Time frame |
|---|---|
| NoneTimepoint: None | — |
Countries
India
Contacts
Public ContactDr Ankita Chugh
AIIMS Jodhpur
Outcome results
None listed